Radiation Dosimetry
ID: 75A50125R00001Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEBARDA - ASPR / DAAPPO / BARDA DCMAWASHINGTON, DC, 20515, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

COMMUNITY AND REGIONAL DEVELOPMENT R&D SERVICES; COMMUNITY DEVELOPMENT; BASIC RESEARCH (AB11)
Timeline
    Description

    The Department of Health and Human Services, specifically the Biomedical Advanced Research and Development Authority (BARDA), is seeking proposals for the development of standardized radiation dosimetry guidelines for nonclinical models utilized in research institutions across its radiation research portfolio. The primary objective is to establish a centralized dosimetry harmonization program that ensures consistent and accurate data, which is crucial for the development of medical countermeasures against chemical, biological, and radiological threats, as well as emerging diseases. This initiative is vital for enhancing public health preparedness through rigorous research standardization and methodology development. Interested parties can contact Audrey Glover at audrey.glover@hhs.gov or Joann Kambaja at Joann.Kambaja@hhs.gov for further details, with the contract structured as a cost-plus-fixed-fee model for an initial two-year base period, extendable up to five years.

    Point(s) of Contact
    Joann Kambaja, Contract Specialist
    Joann.Kambaja@hhs.gov
    Files
    Title
    Posted
    The document outlines a Request for Proposal (RFP) issued by the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services (HHS). It focuses on developing standardized radiation dosimetry guidelines for nonclinical models used in research institutions across BARDA's radiation research portfolio. The objective is to harmonize dosimetry methods to ensure consistent and accurate data for medical countermeasure development against chemical, biological, and radiological threats, as well as emerging diseases. The solicitation details the contract structure, including a cost-plus-fixed-fee model for the initial two-year base period, with options extending up to five years. It emphasizes the importance of establishing a centralized dosimetry harmonization program, including protocol developments, phantom fabrications, and irradiator assessments to maintain data integrity. Furthermore, it outlines deliverables such as progress reports, inventory of irradiators, and standard operating procedures. The document also specifies terms regarding inspection, acceptance, project management, and reporting requirements. It highlights the contractual obligations to provide comprehensive deliverables that align with federal acquisition regulations, ensuring both accountability and compliance throughout the contract's duration. Overall, this RFP is a strategic government initiative to enhance public health preparedness through rigorous research standardization and methodology development.
    Lifecycle
    Title
    Type
    Radiation Dosimetry
    Currently viewing
    Solicitation
    Similar Opportunities
    Decentralized Clinical Operations for Healthcare and Research (D-COHRe) Partnership Solicitation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking proposals for the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) Partnership Solicitation, aimed at establishing partnerships with organizations that provide decentralized healthcare services or have decentralized clinical research capabilities. The initiative focuses on enhancing clinical trial capabilities and medical countermeasure (MCM) development, particularly during public health emergencies, by building a sustainable decentralized clinical research infrastructure. With an anticipated funding amount of up to $100 million distributed over a five-year performance period, proposals are due by December 9, 2024, at 12:00 PM EST. Interested parties can direct inquiries to LaunchOfficeContracting@hhs.gov for proposal submissions and additional information.
    BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Office of Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003, which focuses on innovative medical countermeasures (MCMs) to address public health emergencies. The initiative invites submissions across various Areas of Interest (AOIs), including but not limited to vaccine development, diagnostics, and therapeutics for infectious diseases and chemical threats. This program is crucial for enhancing the nation's preparedness against health security threats, particularly in light of recent global health challenges. Interested parties must register on SAM.gov and adhere to specific submission deadlines, with multiple awards anticipated based on scientific merit and funding availability. For further inquiries, respondents can contact Aarati Singal or Lara Emmons at DRIVeAcquisitions@hhs.gov.
    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
    Active
    Health And Human Services, Department Of
    Solicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) is seeking proposals for various health research and development services. This opportunity is typically used for experimental development and healthcare services. The place of performance is in the USA. For more information, please contact BARDA-BAA@hhs.gov. The deadline for proposal submission is September 25, 2028, at 4:30 PM Eastern Time.
    Navy Occupational Dosimetry System (NODS) - Dosimeters, Readers/Base Stations, and Logistics Hardware
    Active
    Dept Of Defense
    The Department of Defense, through the Naval Surface Warfare Center Carderock Division (NSWCCD), is soliciting proposals for the Navy Occupational Dosimetry System (NODS), which includes dosimeters, readers/base stations, and logistics hardware. The NODS is intended to meet the Navy's physical, radiological, and environmental requirements, incorporating the next generation dosimetry system alongside the Navy Radiation Exposure Management System (NAVREMS) for enhanced radiation health and database management. This procurement is crucial for ensuring the safety and health of Navy personnel exposed to radiation, and the contract will be awarded as a hybrid single award indefinite-delivery/indefinite-quantity (IDIQ) for a period of five years, with five one-year ordering periods. Interested parties should direct inquiries to Carlos Triay at carlos.triay@navy.mil or Haylea Weidinger at haylea.r.witz.civ@us.navy.mil, and monitor SAM.gov and PIEE for updates, including an amendment expected within ten business days.
    BARDA Antibiotic for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia or Bloodstream Infections Caused by Drug-Resistant Bacteria or Biothreat Pathogens
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is issuing a Sources Sought Notice to gather information on antibiotics in development for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) and bloodstream infections (BSI) caused by drug-resistant bacteria. This initiative aims to enhance understanding of the antibiotic development landscape and prepare for future procurement to strengthen U.S. emergency response capabilities against CBRN threats and antibiotic resistance. BARDA is particularly interested in details regarding antibiotic candidates, including their clinical indications, development status, manufacturing plans, and commercialization strategies, with submissions due by November 29, 2025. Interested parties should contact Erin Greninger at erin.greninger@hhs.gov or Audrey Glover at audrey.glover@hhs.gov for further information.
    RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals for the "NextGen Oral Formulation Vaccines for COVID-19" under the Rapid Response Partnership Vehicle (RRPV) Consortium. The objective of this initiative is to advance oral vaccine platforms and technologies into a proof-of-concept Phase 1 clinical trial, enhancing understanding of their potential and improving COVID-19 solutions to bolster preparedness against future health security threats. This effort is critical in the ongoing response to the COVID-19 pandemic and aims to develop innovative vaccine solutions. Interested parties should note that the proposal submission deadline has been extended to November 15, 2024, and can contact Rebecca Harmon at rebecca.harmon@ati.org for further information.
    Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking proposals for the "Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability" through a Special Notice. The objective of this procurement is to establish a long-term partnership focused on developing a flexible and rapid response capability for vaccine development against pandemic influenza and other priority pathogens, initially emphasizing influenza mRNA vaccine development. This initiative is critical for enhancing the nation's preparedness and response to emerging infectious diseases, ensuring readiness to pivot quickly in the face of public health threats. Interested parties can access the full Request for Project Proposals and additional consortium information at www.rrpv.org, and inquiries can be directed to Rebecca Harmon at rebecca.harmon@ati.org.
    2026 NIAID DMID Omnibus Broad Agency Announcement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the 2026 NIAID DMID Omnibus Broad Agency Announcement (BAA) aimed at advancing medical countermeasures against infectious diseases. This opportunity encompasses two primary research areas: the development of therapeutics, vaccines, and diagnostics for antimicrobial-resistant pathogens, and the creation of direct acting antivirals targeting viruses with pandemic potential. The initiative is critical for enhancing public health responses to emerging infectious threats and includes funding estimates of up to $8.5 million for Research Area 001 and $20 million for Research Area 002, with proposals due to be submitted online via the NIAID electronic Contract Proposal Submission (eCPS) platform, starting around November 22, 2024. For further inquiries, interested parties may contact Swee L. Teo at teosl@niaid.nih.gov or Brian Madgey at brian.madgey@nih.gov.
    FY24 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Award Notice
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), has announced the FY24 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. This opportunity aims to support innovative research projects that enhance regulatory science, with a focus on health, medical, and biotechnology advancements. The awarded contracts, totaling over $24 million, cover a range of critical topics including drug safety, gene therapy, and methodologies for assessing pediatric opioid exposure, reflecting the federal government's commitment to fostering research initiatives that improve healthcare delivery and regulatory processes. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    BARDA DRIVe EZ-BAA-22-100-SOL-00003
    Active
    Health And Human Services, Department Of
    Solicitation: HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking proposals for BARDA DRIVe EZ-BAA-22-100-SOL-00003. This procurement is for health research and development services, health care services, and experimental development. The announcement serves as a reissuance of the BARDA DRIVe EZ-BAA and supersedes prior iterations. For more information, please visit https://drive.hhs.gov/.